Immunostimulatory DNA as adjuvant: efficacy of phosphodiester CpG oligonucleotides is enhanced by 3' sequence modifications

By Zimmermann S.   Heeg K.   Dalpke A.  

Vaccine, Vol. 21, Iss. 9, 2003-02 ,pp. : 990-995

Elsevier

Access to resources Recommend Favorite

CpG motifs as immune adjuvants

By Klinman D.M.   Barnhart K.M.   Conover J.  

Vaccine, Vol. 17, Iss. 1, 1999-01 ,pp. : 19-25

Elsevier

Access to resources Recommend Favorite

Immune effects and mechanisms of action of CpG motifs

By Krieg A.M.  

Vaccine, Vol. 19, Iss. 6, 2000-11 ,pp. : 618-622

Elsevier

Access to resources Recommend Favorite

Poly-l-arginine synergizes with oligodeoxynucleotides containing CpG-motifs (CpG-ODN) for enhanced and prolonged immune responses and prevents the CpG-ODN-induced systemic release of pro-inflammatory cytokines

By Lingnau K.   Egyed A.   Schellack C.   Mattner F.   Buschle M.   Schmidt W.  

Vaccine, Vol. 20, Iss. 29, 2002-10 ,pp. : 3498-3508

Elsevier

Access to resources Recommend Favorite

CpG-containing oligodeoxynucleotides augment and switch the immune responses of cattle to bovine herpesvirus-1 glycoprotein D

By Rankin R.   Pontarollo R.   Gomis S.   Karvonen B.   Willson P.   Loehr B.I.   Godson D.L.   Babiuk L.A.   Hecker R.   van Drunen Littel-van den Hurk S.  

Vaccine, Vol. 20, Iss. 23, 2002-07 ,pp. : 3014-3022

Elsevier

Access to resources Recommend Favorite